European Archives - Page 787 of 1096 - European Medical Journal

EMJ Hepatology 6.1 Now Available

EMJ Hepatology 6.1 has arrived. This impressive eJournal marks the European Medical Journal’s third specialist publication to be released this year…

ILC 2018 - Congress Highlights

Here’s a look into the venue of this year’s International Liver Congress (ILC), for the 53rd annual meeting.

EMJ Hepatology 6.1 2018

EMJ Hepatology 6.1 has arrived. This impressive eJournal marks the European Medical Journal’s third specialist publication to be released this year…

Review of the 53rd International Liver Congress™ 2018

Bigger and better than ever before, this year’s dynamic EASL ILC was held in Paris, France from the 11th–15th April 2018. This historic city, long…

Resolution of Ascites, Hepatic Encephalopathy, and Variceal Bleeding in Patients with Hepatitis C Virus and Decompensated Cirrhosis Who Received All-Oral Direct-Acting Antiviral Treatment

Worldwide, 185 million people are infected with the hepatitis C virus (HCV);1 approximately 12% of these individuals have manifestations of decompensated…

ILC 2018 - Interview - Dr Dhiraj Tripathi

An interview with Dr Dhiraj Tripathi (Queen Elizabeth Hospital Birmingham, UK) at this year’s ILC congress held in Paris, France.

Editor's Pick: Primary Hepatic Angiosarcoma: A Brief Review of the Literature

Primary hepatic angiosarcoma (HAS) is a liver tumour of endothelial cell origin. It is the most common malignant mesenchymal tumour of the liver…

A Comparison of Renal Function Before and After Treatment of Chronic Hepatitis C Infection in Patients Who Achieve Sustained Virological Response with Direct-Acting Antivirals

Approximately 3 million people have chronic hepatitis C virus (HCV) infection in the USA. However, there are limited data with regard to the effect of…

OPTIMIS: Real-World Data in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolisation: Second Interim Analysis

Transarterial chemoembolisation (TACE) is the most common treatment modality for hepatocellular carcinoma (HCC) worldwide, often used to treat cases…

Acute Fatty Liver of Pregnancy: Better Understanding of Pathogenesis and Earlier Clinical Recognition Results in Improved Maternal Outcomes

Acute fatty liver of pregnancy (AFLP) is an uncommon disorder affecting women in late pregnancy. It is increasingly recognised as an important cause of…